Table 2.
Values of NLR, PLR, and Hb/RDW in 180 patients with nasopharyngeal cancer.
Indicators | N | Hb/RDW | P | NLR | P | PLR | P |
Stage | |||||||
I+II | 84 | 989.87 ± 166.42 | .152 | 2.67 ± 1.73 | .043 | 147.53 ± 57.28 | .424 |
III+IV | 96 | 967.02 ± 171.00 | 3.27 ± 2.37 | 170.05 ± 98.92 | |||
Serosal invasion | |||||||
T1+T2 | 56 | 1004.26 ± 142.69 | .182 | 2.57 ± 1.68 | .055 | 136.68 ± 50.03 | .031 |
T3+T4 | 124 | 965.68 ± 178.58 | 3.18 ± 2.26 | 169.87 ± 92.15 | |||
Lymph node metastasis | |||||||
Absence | 84 | 985.20 ± 165.48 | .301 | 2.66 ± 1.74 | .030 | 146.80 ± 57.40 | .313 |
Presence | 96 | 971.11 ± 172.23 | 3.28 ± 2.36 | 170.69 ± 98.71 | |||
Distant metastasis | |||||||
Absence | 171 | 983.11 ± 166.97 | .065 | 2.98 ± 2.13 | .570 | 158.43 ± 79.29 | .745 |
Presence | 9 | 874.65 ± 180.30 | 3.25 ± 1.81 | 180.71 ± 137.72 |
P value was analyzed by the Kruskal–Wallis H test or the Wilcoxon rank-sum test.
Hb/RDW = hemoglobin-to-red cell distribution width ratio (Hb/RDW), NLR = neutrophil-to-lymphocyte ratio, PLR = platelet-to-lymphocyte ratio.